AI and wearables join forces to uncover Dementia's hidden clues

NCT ID NCT07651085

Ongoing Knowledge-focused Sponsor: IRCCS San Raffaele Roma Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates how genetic, lifestyle, and biological factors relate to memory and thinking problems in people over 60 with Alzheimer's disease, Parkinson's disease, or mild cognitive impairment. Researchers will use brain scans, spinal fluid and blood tests, and data from smartwatches and tablets to look for patterns that might predict cognitive decline. The goal is to better understand what contributes to dementia in these conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help identify early warning signs or risk factors for dementia in Alzheimer's and Parkinson's patients, potentially guiding future prevention or treatment strategies.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any drug or therapy, and the findings may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia Parkinson disease sleep-wake disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE DEMENTIA MILD COGNITIVE IMPAIRMENT PARKINSON DISEASE

Contacts and locations

Locations

IRCCS San Raffaele Roma

Rome, Italy, 00163, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.